- Home
- INTS vs PETZ Comparison
INTS vs PETZ Comparison
Compare INTS & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- PETZ
- Stock Information
- Founded
- INTS 2012
- PETZ 2002
- Country
- INTS United States
- PETZ China
- Employees
- INTS N/A
- PETZ N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- PETZ Steel/Iron Ore
- Sector
- INTS Health Care
- PETZ Industrials
- Exchange
- INTS Nasdaq
- PETZ Nasdaq
- Market Cap
- INTS 12.2M
- PETZ 10.0M
- IPO Year
- INTS 2023
- PETZ 2017
- Fundamental
- Price
- INTS $0.42
- PETZ $0.96
- Analyst Decision
- INTS Strong Buy
- PETZ
- Analyst Count
- INTS 4
- PETZ 0
- Target Price
- INTS $4.50
- PETZ N/A
- AVG Volume (30 Days)
- INTS 87.5M
- PETZ 7.9K
- Earning Date
- INTS 11-06-2025
- PETZ 11-13-2025
- Dividend Yield
- INTS N/A
- PETZ N/A
- EPS Growth
- INTS N/A
- PETZ N/A
- EPS
- INTS N/A
- PETZ 0.26
- Revenue
- INTS N/A
- PETZ $1,046,006.00
- Revenue This Year
- INTS N/A
- PETZ N/A
- Revenue Next Year
- INTS N/A
- PETZ N/A
- P/E Ratio
- INTS N/A
- PETZ $6.00
- Revenue Growth
- INTS N/A
- PETZ N/A
- 52 Week Low
- INTS $0.19
- PETZ $0.65
- 52 Week High
- INTS $3.18
- PETZ $1.68
- Technical
- Relative Strength Index (RSI)
- INTS 50.05
- PETZ 36.47
- Support Level
- INTS $0.38
- PETZ $1.00
- Resistance Level
- INTS $0.50
- PETZ $1.04
- Average True Range (ATR)
- INTS 0.07
- PETZ 0.04
- MACD
- INTS -0.02
- PETZ -0.01
- Stochastic Oscillator
- INTS 18.75
- PETZ 6.25
About INTS Intensity Therapeutics Inc.
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.